Structure-Based Virtual Screening for Drug Discovery: a Problem-Centric Review
Journal Title: The AAPS Journal - Year 2012, Vol 14, Issue 1
Abstract
Structure-based virtual screening (SBVS) has been widely applied in early-stage drug discovery. From a problem-centric perspective, we reviewed the recent advances and applications in SBVS with a special focus on docking-based virtual screening. We emphasized the researchers’ practical efforts in real projects by understanding the ligand-target binding interactions as a premise. We also highlighted the recent progress in developing target-biased scoring functions by optimizing current generic scoring functions toward certain target classes, as well as in developing novel ones by means of machine learning techniques.
Authors and Affiliations
Tiejun Cheng, Qingliang Li, Zhigang Zhou, Yanli Wang, Stephen H. Bryant
Keywords
Related Articles
- EP ID EP681194
- DOI 10.1208/s12248-012-9322-0
- Views 84
- Downloads 0
Development and Fit-for-Purpose Validation of a Soluble Human Programmed Death-1 Protein Assay
The online version of this article (doi:10.1208/s12248-015-9762-4) contains supplementary material, which is available to authorized users.
In Vitro Testing for Orally Inhaled Products: Developments in Science-Based Regulatory Approaches
This article is part of a series of reports from the “Orlando Inhalation Conference-Approaches in International Regulation” which was held in March 2014, and coorganized by the University of Florida and t...
Microparticles for Inhalational Delivery of Antipseudomonal Antibiotics
Chronic pseudomonal bronchopulmonary infections in cystic fibrosis patients are frequently controlled with inhaled antibiotics. Dry-powder inhalable antibiotics are an attractive alternative to nebulized medications. We...
Bioequivalence studies for levothyroxine
The Food and Drug Administration (FDA) Guidance for Bioavailability and Bioequivalence Studies for Levothyroxine has been challenged by companies that manufacture brand-name products. Their contention is that the current...
Equivalence studies for complex active ingredients and dosage forms
This article examines the United States Pharmacopeia (USP) and its role in assessing the equivalence and inequivalence of biological and biotechnological drug substances and products—a role USP has played since i...